{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:11:01Z","timestamp":1794107461164,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["IG202 ID 24529"],"award-info":[{"award-number":["IG202 ID 24529"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CUP J93C22000530006"],"award-info":[{"award-number":["CUP J93C22000530006"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.biopha.2025.117946","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T18:03:41Z","timestamp":1740765821000},"page":"117946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Anti-miRNA therapeutics for uterine fibroids"],"prefix":"10.1016","volume":"185","author":[{"given":"Sharad","family":"Saxena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8315-2258","authenticated-orcid":false,"given":"Chiara","family":"Agostinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1627-4404","authenticated-orcid":false,"given":"Simone","family":"Vodret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6006-6544","authenticated-orcid":false,"given":"Nadja Anneliese Ruth","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Colliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Vuerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9827-6755","authenticated-orcid":false,"given":"Luca","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1770-2386","authenticated-orcid":false,"given":"A.","family":"Cook-Calvete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Zito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Di","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blendi","family":"Ura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9277-9378","authenticated-orcid":false,"given":"Maurizio","family":"Pinamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Zacchigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.117946_bib1","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2025.117946_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bpobgyn.2008.04.002","article-title":"Incidence, aetiology and epidemiology of uterine fibroids","volume":"22","author":"Okolo","year":"2008","journal-title":"Best. Pr. Res Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.biopha.2025.117946_bib3","first-page":"424","article-title":"Epidemiology of Uterine Myomas: A Review","volume":"9","author":"Sparic","year":"2016","journal-title":"Int J. Fertil. Steril."},{"key":"10.1016\/j.biopha.2025.117946_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6874-12-6","article-title":"Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women","volume":"12","author":"Zimmermann","year":"2012","journal-title":"BMC Women\u2019s. Health"},{"key":"10.1016\/j.biopha.2025.117946_bib5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/endrev\/bnab039","article-title":"Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment","volume":"43","author":"Yang","year":"2022","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.biopha.2025.117946_bib6","first-page":"16","article-title":"Uterine Fibroids: Hiding in Plain Sight","volume":"37","author":"Stewart","year":"2022","journal-title":"Physiol. (Bethesda)"},{"key":"10.1016\/j.biopha.2025.117946_bib7","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/AOG.0000000000004988","article-title":"Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas","volume":"140","author":"Al-Hendy","year":"2022","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.biopha.2025.117946_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18031066","article-title":"Uterine Fibroids and Diet","volume":"18","author":"Tinelli","year":"2021","journal-title":"Int J. Environ. Res Public Health"},{"key":"10.1016\/j.biopha.2025.117946_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/2516865720904057","article-title":"Phthalate Exposures and MicroRNA Expression in Uterine Fibroids: The FORGE Study","volume":"13","author":"Zota","year":"2020","journal-title":"Epigenet Insights"},{"key":"10.1016\/j.biopha.2025.117946_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/1933719117711265","article-title":"Expression Profiling of lncRNAs, miRNAs, and mRNAs and Their Differential Expression in Leiomyoma Using Next-Generation RNA Sequencing","volume":"25","author":"Chuang","year":"2018","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.biopha.2025.117946_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.117946_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ymthe.2024.12.037","article-title":"Functional screening identifies novel miRNAs inhibiting Vascular Smooth Muscle Cell proliferation","volume":"33","author":"Rodor","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2025.117946_bib13","article-title":"MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer","volume":"11","author":"Yu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.117946_bib14","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/cdd.2011.28","article-title":"MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer","volume":"18","author":"Zhang","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2025.117946_bib15","first-page":"630","article-title":"Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis","volume":"123","author":"Xu","year":"2013","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2025.117946_bib16","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1007\/s12032-012-0210-3","article-title":"Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma","volume":"29","author":"Huang","year":"2012","journal-title":"Med Oncol."},{"key":"10.1016\/j.biopha.2025.117946_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010052","article-title":"Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells","volume":"19","author":"de Almeida","year":"2017","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117946_bib18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/PAI.0000000000000619","article-title":"The Use of Smoothelin and Other Antibodies in the Diagnosis of Uterine and Soft Tissue Smooth Muscle Tumors","volume":"27","author":"Mayhall","year":"2019","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.biopha.2025.117946_bib19","first-page":"26","article-title":"Transgelin, a Novel Marker of Smooth Muscle Differentiation, Effectively Distinguishes Endometrial Stromal Tumors from Uterine Smooth Muscle Tumors","volume":"1","author":"Tawfik","year":"2014","journal-title":"Int J. Gynecol. Obstet. Reprod. Med Res"},{"key":"10.1016\/j.biopha.2025.117946_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2015.10.003","article-title":"Exploring miRNA based approaches in cancer diagnostics and therapeutics","volume":"98","author":"Mishra","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biopha.2025.117946_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.biopha.2006.07.078","article-title":"An LNA-based loss-of-function assay for micro-RNAs","volume":"60","author":"Naguibneva","year":"2006","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.117946_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-4598-12-43","article-title":"The microRNA-148\/152 family: multi-faceted players","volume":"12","author":"Chen","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2025.117946_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jmcb\/mjs049","article-title":"A regulatory circuit of miR-148a\/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1","volume":"5","author":"Xu","year":"2013","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117946_bib24","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/jcmm.14045","article-title":"Inhibition of miR-148a-3p resists hepatocellular carcinoma progress of hepatitis C virus infection through suppressing c-Jun and MAPK pathway","volume":"23","author":"Deng","year":"2019","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2025.117946_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13046-020-01649-0","article-title":"MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner","volume":"39","author":"Huang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.117946_bib26","first-page":"6131","article-title":"miR-148a-3p suppresses epithelial ovarian cancer progression primarily by targeting c-Met","volume":"15","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2025.117946_bib27","first-page":"402","article-title":"Overexpression of miR-148a inhibits viability and invasion of ovarian cancer OVCAR3 cells by targeting FOXO3","volume":"18","author":"Zhu","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2025.117946_bib28","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1158\/1078-0432.CCR-11-1714","article-title":"MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer","volume":"17","author":"Zheng","year":"2011","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2025.117946_bib29","doi-asserted-by":"crossref","first-page":"8650","DOI":"10.1073\/pnas.1500886112","article-title":"MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC","volume":"112","author":"Joshi","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.117946_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113419","article-title":"Antagonism of miR-148a attenuates atherosclerosis progression in APOBTGApobec-\/-Ldlr+\u2009\/- mice: A brief report","volume":"153","author":"Rotllan","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.117946_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.143948","article-title":"MicroRNA-148a-3p promotes survival and migration of endothelial cells isolated from Apoe deficient mice through restricting circular RNA 0003575","volume":"711","author":"Shang","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2025.117946_bib32","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/dna.2017.3651","article-title":"Reciprocal Regulation Between miR-148a\/152 and DNA Methyltransferase 1 Is Associated with Hyperhomocysteinemia-Accelerated Atherosclerosis","volume":"36","author":"Yang","year":"2017","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.biopha.2025.117946_bib33","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3892\/or.2015.4502","article-title":"MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1","volume":"35","author":"Jiang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2025.117946_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90972-3","article-title":"Stable duplex-linked antisense targeting miR-148a inhibits breast cancer cell proliferation","volume":"11","author":"Okumura","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.117946_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23454","article-title":"MicroRNA-148a-3p inhibits cancer progression and is a novel screening biomarker for gastric cancer","volume":"34","author":"Bao","year":"2020","journal-title":"J. Clin. Lab Anal."},{"key":"10.1016\/j.biopha.2025.117946_bib36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.7150\/ijbs.7.567","article-title":"miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells","volume":"7","author":"Guo","year":"2011","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.biopha.2025.117946_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1620\/tjem.222.55","article-title":"Establishment of a novel xenograft model for human uterine leiomyoma in immunodeficient mice","volume":"222","author":"Tsuiji","year":"2010","journal-title":"Tohoku J. Exp. Med"},{"key":"10.1016\/j.biopha.2025.117946_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10911-024-09555-3","article-title":"Fast Ultrasound Scanning is a Rapid, Sensitive, Precise and Cost-Effective Method to Monitor Tumor Grafts in Mice","volume":"29","author":"Moli\u00e8re","year":"2024","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.biopha.2025.117946_bib39","doi-asserted-by":"crossref","first-page":"8872","DOI":"10.1038\/s41598-018-27138-1","article-title":"Establishment of a novel mouse xenograft model of human uterine leiomyoma","volume":"8","author":"Suzuki","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.117946_bib40","doi-asserted-by":"crossref","first-page":"C424","DOI":"10.1152\/ajpcell.00405.2018","article-title":"Smooth muscle cell-specific knockout of neuropilin-1 impairs postnatal lung development and pathological vascular smooth muscle cell accumulation","volume":"316","author":"Mahmoud","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2025.117946_bib41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCRESAHA.122.321538","article-title":"TXNIP Suppresses the Osteochondrogenic Switch of Vascular Smooth Muscle Cells in Atherosclerosis","volume":"132","author":"Woo","year":"2023","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2025.117946_bib42","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41420-022-01261-5","article-title":"MiR-148a deletion protects from bone loss in physiological and estrogen-deficient mice by targeting NRP1","volume":"8","author":"Pan","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2025.117946_bib43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yjmcc.2020.02.007","article-title":"M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia\/reperfusion injury via inhibiting TXNIP and the TLR4\/NF-\u03baB\/NLRP3 inflammasome signaling pathway","volume":"142","author":"Dai","year":"2020","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2025.117946_bib44","first-page":"1","article-title":"MicroRNA-148a\/b-3p regulates angiogenesis by targeting neuropilin-1 in endothelial cells","volume":"51","author":"Kim","year":"2019","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.biopha.2025.117946_bib45","doi-asserted-by":"crossref","first-page":"21884","DOI":"10.1074\/jbc.M600427200","article-title":"The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange","volume":"281","author":"Patwari","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.117946_bib46","doi-asserted-by":"crossref","first-page":"21645","DOI":"10.1074\/jbc.274.31.21645","article-title":"Identification of thioredoxin-binding protein-2\/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression","volume":"274","author":"Nishiyama","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.117946_bib47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jb\/mvz105","article-title":"TXNIP induced by MondoA, rather than ChREBP, suppresses cervical cancer cell proliferation, migration and invasion","volume":"167","author":"Zhang","year":"2020","journal-title":"J. Biochem"},{"key":"10.1016\/j.biopha.2025.117946_bib48","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41419-022-04783-z","article-title":"Identification of a novel mechanism for reversal of doxorubicin-induced chemotherapy resistance by TXNIP in triple-negative breast cancer via promoting reactive oxygen-mediated DNA damage","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.117946_bib49","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1158\/1535-7163.MCT-17-1240","article-title":"Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma","volume":"17","author":"Feingold","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2025.117946_bib50","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/molehr\/gat069","article-title":"Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium","volume":"20","author":"Hou","year":"2014","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.biopha.2025.117946_bib51","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3389\/fimmu.2017.01327","article-title":"miR-148a-3p Mediates Notch Signaling to Promote the Differentiation and M1 Activation of Macrophages","volume":"8","author":"Huang","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.117946_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5603\/GP.a2018.0002","article-title":"Neuropilin 1 in uterine leiomyosarcoma. Clinical and pathological analysis","volume":"89","author":"Bobi\u0144ski","year":"2018","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.biopha.2025.117946_bib53","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1096\/fj.201800243RRR","article-title":"circDiaph3 regulates rat vascular smooth muscle cell differentiation, proliferation, and migration","volume":"33","author":"Xu","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2025.117946_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071757","article-title":"The Thioredoxin System of Mammalian Cells and Its Modulators","volume":"10","author":"Hasan","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2025.117946_bib55","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/laban.254","article-title":"Estimation of rat mammary tumor volume using caliper and ultrasonography measurements","volume":"42","author":"Faustino-Rocha","year":"2013","journal-title":"Lab Anim. (NY)"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:50:41Z","timestamp":1762311041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225001404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":55,"alternative-id":["S0753332225001404"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117946","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-miRNA therapeutics for uterine fibroids","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117946"}}